---
title: "Analytical Biotech Fund, LP SEC filings"
url: https://altstreet.investments/edgar/2108298
kind: edgar-entity
updated: 2026-07-31
publisher: AltStreet (https://altstreet.investments)
license: Public factual pages may be read, quoted and cited with attribution and a link. Bulk redistribution is not permitted.
---

# Analytical Biotech Fund, LP: SEC filings and what they report

Analytical Biotech Fund, LP is a Delaware limited partnership filing under Rule 506(b) and Section 3(c)(1), indicating a private hedge fund structure. The filing is pre-open with no capital raised or investor count disclosed; minimum investment is set at $500K. The fund is promoted by Syno Partners, LLC and Syno Capital, LLC, with executive officers Joseph Weilgus and Justin Xiang.

| Field | Value |
| --- | --- |
| Entity | Analytical Biotech Fund, LP |
| CIK | 2108298 |
| Filing family | 506(b), 3(c)(1) |
| Entity type | fund vehicle |
| Manager (as filed) | Syno Capital |
| Platform | Analytical Biotech Fund, LP (https://altstreet.investments/platforms/analytical-biotech-fund-lp) |
| Newest fact-bearing filing | March 31, 2026, accession 0002108298-26-000001 |
| Total sold (as reported) | $0 |
| Investors (as reported) | 0 |
| Minimum investment (as filed) | $500,000 |
| Vintage | 2026 |

## Related persons (Form D Item 3)

| Name | Relationship |
| --- | --- |
| n/a Syno Partners, LLC | Promoter |
| n/a Syno Capital, LLC | Promoter |
| Joseph Weilgus | Executive Officer |
| Justin Xiang | Executive Officer |


## Filings (1 on record, newest first)

| Date | Form | Family | SEC link |
| --- | --- | --- | --- |
| March 31, 2026 | D | Form D | https://www.sec.gov/Archives/edgar/data/2108298/000210829826000001/ |


## More

- Entity page (HTML, with events, parties and the platform record): https://altstreet.investments/edgar/2108298
- SEC EDGAR filing index: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002108298&owner=include&count=40
- Other issuers on Analytical Biotech Fund, LP: https://altstreet.investments/deals/platform/analytical-biotech-fund-lp
- Signal history, evidence passages and the entity graph are AltStreet Terminal features: https://altstreet.investments/terminal

---

Source page: https://altstreet.investments/edgar/2108298
Machine index: https://altstreet.investments/llms.txt
AltStreet reads what platforms, funds and issuers file with the SEC and what they tell investors, and publishes the difference. Figures are as filed or as captured on the date stated; nothing here is investment advice.